Zdrowie i gospodarka · 26/07/2022

FDA Requests Public Comment on Proposed Information Collection for The Real Cost Campaign Outcomes Evaluation Study: Cohort 3

The Food and Drug Administration is seeking public input on a proposed information collection, as required by the Paperwork Reduction Act of 1995, to evaluate the outcomes of The Real Cost Campaign: Cohort 3